| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 18.151 | 282.341 | 304.326 | 225.848 | 205.221 |
| Total Income - EUR | - | - | - | - | - | 18.151 | 282.355 | 533.857 | 431.381 | 348.784 |
| Total Expenses - EUR | - | - | - | - | - | 3.645 | 132.957 | 259.102 | 234.996 | 442.704 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 14.506 | 149.398 | 274.755 | 196.384 | -93.920 |
| Net Profit/Loss - EUR | - | - | - | - | - | 14.324 | 147.074 | 269.417 | 188.560 | -93.920 |
| Employees | - | - | - | - | - | 1 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Versus Pharma Management S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 24.203 | 537.738 | 944.888 | 1.395.609 |
| Current Assets | - | - | - | - | - | 20.235 | 191.778 | 307.344 | 491.489 | 386.098 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 231.970 | 31.731 |
| Receivables | - | - | - | - | - | 17.118 | 181.810 | 60.151 | 167.432 | 198.210 |
| Cash | - | - | - | - | - | 3.117 | 9.968 | 247.193 | 92.088 | 156.157 |
| Shareholders Funds | - | - | - | - | - | 14.366 | 161.122 | 299.738 | 487.389 | 390.745 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 5.869 | 54.859 | 545.343 | 948.988 | 1.390.962 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7010 - 7010" | |||||||||
| CAEN Financial Year |
7010
|
|||||||||
Comments - Versus Pharma Management S.r.l.